ArticleMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents2026

Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation.

Jeffrey Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.